Last reviewed · How we verify

Chlorhexidine/Thymol varnish

Rosa Moreno Lopez · FDA-approved active Small molecule

Chlorhexidine and thymol work together as antimicrobial and antifungal agents in a varnish formulation applied topically to oral tissues.

Chlorhexidine and thymol work together as antimicrobial and antifungal agents in a varnish formulation applied topically to oral tissues. Used for Oral antimicrobial prophylaxis and treatment, Candidiasis prevention and treatment, Plaque and gingivitis management.

At a glance

Generic nameChlorhexidine/Thymol varnish
Also known asCervitec Plus (1% chlorhexidine plus 1% thymol)
SponsorRosa Moreno Lopez
Drug classAntimicrobial/antifungal varnish
ModalitySmall molecule
Therapeutic areaDentistry/Oral Health
PhaseFDA-approved

Mechanism of action

Chlorhexidine is a broad-spectrum antimicrobial that disrupts bacterial cell membranes and inhibits bacterial metabolism, while thymol is a natural phenolic compound with antimicrobial and antifungal properties. When combined in a varnish formulation, they provide sustained local delivery to oral tissues for prevention and treatment of oral infections, plaque, and fungal conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: